Cluster composition

Functions

Category	Name	IntersectionWithQuery	PValue	GenesInTerm	GenesInQuery	GenesInTermInQuery	ID
GeneOntologyMolecularFunction	chromatin binding	PWWP2A MLLT3 MBTD1 CENPS ZNF609 REST EP300 BRD4 HNRNPU	3.19e-07	739	27	9	GO:0003682
GeneOntologyMolecularFunction	modification-dependent protein binding	PWWP2A MLLT3 MBTD1 EP300 BRD4	7.47e-06	206	27	5	GO:0140030
GeneOntologyMolecularFunction	acetylation-dependent protein binding	MLLT3 EP300 BRD4	9.66e-06	31	27	3	GO:0140033
GeneOntologyMolecularFunction	neuroligin family protein binding	NRXN3 NRXN1	1.76e-05	5	27	2	GO:0097109
GeneOntologyMolecularFunction	transcription coregulator activity	C1D PA2G4 MTDH EP300 BRD4 HNRNPU	8.65e-05	562	27	6	GO:0003712
GeneOntologyMolecularFunction	RNA polymerase II C-terminal domain binding	BRD4 HNRNPU	9.61e-05	11	27	2	GO:0099122
GeneOntologyMolecularFunction	promoter-specific chromatin binding	ZNF609 EP300 HNRNPU	1.88e-04	83	27	3	GO:1990841
GeneOntologyMolecularFunction	histone binding	PWWP2A MLLT3 MBTD1 BRD4	4.18e-04	265	27	4	GO:0042393
GeneOntologyMolecularFunction	transcription factor binding	C1D REST MTDH EP300 PCLO HNRNPU	4.23e-04	753	27	6	GO:0008134
GeneOntologyMolecularFunction	lysine-acetylated histone binding	MLLT3 BRD4	7.48e-04	30	27	2	GO:0070577
GeneOntologyMolecularFunction	NF-kappaB binding	MTDH EP300	1.08e-03	36	27	2	GO:0051059
GeneOntologyMolecularFunction	RNA polymerase II complex binding	BRD4 HNRNPU	1.27e-03	39	27	2	GO:0000993
GeneOntologyMolecularFunction	RNA polymerase core enzyme binding	BRD4 HNRNPU	1.68e-03	45	27	2	GO:0043175
GeneOntologyMolecularFunction	molecular adaptor activity	C1D MLLT3 PA2G4 MTDH EP300 BRD4 HNRNPU	1.74e-03	1356	27	7	GO:0060090
GeneOntologyMolecularFunction	RNA polymerase II-specific DNA-binding transcription factor binding	C1D REST MTDH EP300	2.25e-03	417	27	4	GO:0061629
GeneOntologyMolecularFunction	calcium channel regulator activity	NRXN3 NRXN1	2.41e-03	54	27	2	GO:0005246
GeneOntologyMolecularFunction	pre-mRNA binding	EP300 HNRNPU	3.37e-03	64	27	2	GO:0036002
GeneOntologyMolecularFunction	RNA polymerase binding	BRD4 HNRNPU	3.47e-03	65	27	2	GO:0070063
GeneOntologyMolecularFunction	transcription corepressor activity	C1D PA2G4 HNRNPU	3.55e-03	229	27	3	GO:0003714
GeneOntologyMolecularFunction	basal RNA polymerase II transcription machinery binding	BRD4 HNRNPU	3.58e-03	66	27	2	GO:0001099
GeneOntologyMolecularFunction	basal transcription machinery binding	BRD4 HNRNPU	3.58e-03	66	27	2	GO:0001098
GeneOntologyMolecularFunction	protein-macromolecule adaptor activity	C1D PA2G4 MTDH EP300 BRD4 HNRNPU	3.91e-03	1160	27	6	GO:0030674
GeneOntologyMolecularFunction	p53 binding	EP300 BRD4	4.84e-03	77	27	2	GO:0002039
GeneOntologyMolecularFunction	double-stranded RNA binding	MTDH HNRNPU	4.96e-03	78	27	2	GO:0003725
GeneOntologyMolecularFunction	methylated histone binding	PWWP2A MBTD1	6.00e-03	86	27	2	GO:0035064
GeneOntologyMolecularFunction	methylation-dependent protein binding	PWWP2A MBTD1	6.27e-03	88	27	2	GO:0140034
GeneOntologyMolecularFunction	DNA-binding transcription factor binding	C1D REST MTDH EP300	7.36e-03	582	27	4	GO:0140297
GeneOntologyMolecularFunction	transcription coactivator activity	MTDH EP300 BRD4	7.73e-03	303	27	3	GO:0003713
GeneOntologyBiologicalProcess	presynaptic active zone assembly	NRXN1 PCLO	1.52e-05	5	26	2	GO:1904071
GeneOntologyBiologicalProcess	neuronal signal transduction	NRXN1 MACO1	4.26e-05	8	26	2	GO:0023041
GeneOntologyBiologicalProcess	positive regulation of T-helper 17 cell lineage commitment	EP300 BRD4	4.26e-05	8	26	2	GO:2000330
GeneOntologyBiologicalProcess	viral transcription	REST EP300 BRD4	5.24e-05	58	26	3	GO:0019083
GeneOntologyBiologicalProcess	presynaptic active zone organization	NRXN1 PCLO	6.83e-05	10	26	2	GO:1990709
GeneOntologyBiologicalProcess	regulation of T-helper 17 cell lineage commitment	EP300 BRD4	8.35e-05	11	26	2	GO:2000328
GeneOntologyBiologicalProcess	chromatin organization	PWWP2A MLLT3 MBTD1 REST EP300 BRD4 HNRNPU	9.08e-05	896	26	7	GO:0006325
GeneOntologyBiologicalProcess	positive regulation of T-helper 17 cell differentiation	EP300 BRD4	1.38e-04	14	26	2	GO:2000321
GeneOntologyBiologicalProcess	negative regulation by host of viral transcription	REST BRD4	1.59e-04	15	26	2	GO:0043922
GeneOntologyBiologicalProcess	protein-DNA complex organization	PWWP2A MLLT3 MBTD1 REST EP300 BRD4 HNRNPU	1.79e-04	999	26	7	GO:0071824
GeneOntologyBiologicalProcess	neuron cell-cell adhesion	NRXN3 NRXN1	1.81e-04	16	26	2	GO:0007158
GeneOntologyBiologicalProcess	modulation by host of symbiont process	REST EP300 BRD4	2.01e-04	91	26	3	GO:0051851
GeneOntologyBiologicalProcess	regulation of transcription elongation by RNA polymerase II	PWWP2A BRD4 HNRNPU	2.14e-04	93	26	3	GO:0034243
GeneOntologyBiologicalProcess	positive regulation of cell fate commitment	EP300 BRD4	2.31e-04	18	26	2	GO:0010455
GeneOntologyBiologicalProcess	regulation of DNA-templated transcription elongation	PWWP2A BRD4 HNRNPU	3.06e-04	105	26	3	GO:0032784
GeneOntologyBiologicalProcess	viral gene expression	REST EP300 BRD4	3.42e-04	109	26	3	GO:0019080
GeneOntologyBiologicalProcess	T-helper 17 cell lineage commitment	EP300 BRD4	3.48e-04	22	26	2	GO:0072540
GeneOntologyBiologicalProcess	synaptic vesicle clustering	NRXN1 PCLO	3.48e-04	22	26	2	GO:0097091
GeneOntologyBiologicalProcess	positive regulation of T-helper 17 type immune response	EP300 BRD4	3.80e-04	23	26	2	GO:2000318
GeneOntologyBiologicalProcess	protein-containing complex localization	RALB NRXN3 NRXN1 HNRNPU	3.82e-04	278	26	4	GO:0031503
GeneOntologyBiologicalProcess	regulation of organelle assembly	RALB NRXN1 FEZ2 HNRNPU	3.93e-04	280	26	4	GO:1902115
GeneOntologyBiologicalProcess	organelle assembly	BCCIP RALB NRXN3 NRXN1 FEZ2 EP300 HNRNPU	3.98e-04	1138	26	7	GO:0070925
GeneOntologyBiologicalProcess	protein localization to synapse	NRXN3 NRXN1 PCLO	4.00e-04	115	26	3	GO:0035418
GeneOntologyBiologicalProcess	vocalization behavior	NRXN3 NRXN1	4.15e-04	24	26	2	GO:0071625
GeneOntologyBiologicalProcess	trans-synaptic signaling, modulating synaptic transmission	NRXN3 NRXN1	4.87e-04	26	26	2	GO:0099550
GeneOntologyBiologicalProcess	T-helper cell lineage commitment	EP300 BRD4	5.26e-04	27	26	2	GO:0002295
GeneOntologyBiologicalProcess	transcription elongation by RNA polymerase II	PWWP2A BRD4 HNRNPU	5.34e-04	127	26	3	GO:0006368
GeneOntologyBiologicalProcess	biological process involved in interaction with symbiont	REST EP300 BRD4	6.39e-04	135	26	3	GO:0051702
GeneOntologyBiologicalProcess	CD4-positive, alpha-beta T cell lineage commitment	EP300 BRD4	6.95e-04	31	26	2	GO:0043373
GeneOntologyBiologicalProcess	positive regulation of T-helper cell differentiation	EP300 BRD4	6.95e-04	31	26	2	GO:0045624
GeneOntologyBiologicalProcess	positive regulation of T cell differentiation	ZNF609 EP300 BRD4	7.70e-04	144	26	3	GO:0045582
GeneOntologyBiologicalProcess	DNA-templated transcription elongation	PWWP2A BRD4 HNRNPU	7.70e-04	144	26	3	GO:0006354
GeneOntologyBiologicalProcess	alpha-beta T cell lineage commitment	EP300 BRD4	7.88e-04	33	26	2	GO:0002363
GeneOntologyBiologicalProcess	negative regulation of stem cell differentiation	REST HNRNPU	7.88e-04	33	26	2	GO:2000737
GeneOntologyBiologicalProcess	regulation of T-helper 17 cell differentiation	EP300 BRD4	7.88e-04	33	26	2	GO:2000319
GeneOntologyBiologicalProcess	protein localization to cell junction	NRXN3 NRXN1 PCLO	8.34e-04	148	26	3	GO:1902414
GeneOntologyBiologicalProcess	negative regulation of miRNA metabolic process	REST EP300	8.36e-04	34	26	2	GO:2000629
GeneOntologyBiologicalProcess	postsynaptic density assembly	NRXN3 NRXN1	8.36e-04	34	26	2	GO:0097107
GeneOntologyBiologicalProcess	CD4-positive or CD8-positive, alpha-beta T cell lineage commitment	EP300 BRD4	8.86e-04	35	26	2	GO:0043369
GeneOntologyBiologicalProcess	DNA damage response	BCCIP MBTD1 CENPS KIN EP300 BRD4	1.03e-03	959	26	6	GO:0006974
GeneOntologyBiologicalProcess	response to glucocorticoid	REST EP300 HNRNPU	1.04e-03	160	26	3	GO:0051384
GeneOntologyBiologicalProcess	positive regulation of lymphocyte differentiation	ZNF609 EP300 BRD4	1.08e-03	162	26	3	GO:0045621
GeneOntologyBiologicalProcess	maintenance of synapse structure	NRXN1 PCLO	1.16e-03	40	26	2	GO:0099558
GeneOntologyBiologicalProcess	regulation of chromatin organization	MLLT3 HNRNPU	1.16e-03	40	26	2	GO:1902275
GeneOntologyBiologicalProcess	positive regulation of binding	RALB EP300 BRD4	1.24e-03	170	26	3	GO:0051099
GeneOntologyBiologicalProcess	T cell lineage commitment	EP300 BRD4	1.28e-03	42	26	2	GO:0002360
GeneOntologyBiologicalProcess	negative regulation of DNA-templated transcription	C1D MBTD1 REST PA2G4 MTDH EP300 HNRNPU	1.36e-03	1399	26	7	GO:0045892
GeneOntologyBiologicalProcess	postsynaptic specialization assembly	NRXN3 NRXN1	1.40e-03	44	26	2	GO:0098698
GeneOntologyBiologicalProcess	regulation of binding	RALB REST EP300 BRD4	1.43e-03	396	26	4	GO:0051098
GeneOntologyBiologicalProcess	negative regulation of RNA biosynthetic process	C1D MBTD1 REST PA2G4 MTDH EP300 HNRNPU	1.44e-03	1413	26	7	GO:1902679
GeneOntologyBiologicalProcess	positive regulation of CD4-positive, alpha-beta T cell differentiation	EP300 BRD4	1.46e-03	45	26	2	GO:0043372
GeneOntologyBiologicalProcess	regulation of autophagy	RALB FEZ2 MTDH EP300	1.49e-03	400	26	4	GO:0010506
GeneOntologyBiologicalProcess	excitatory synapse assembly	NRXN3 NRXN1	1.53e-03	46	26	2	GO:1904861
GeneOntologyBiologicalProcess	positive regulation of molecular function	RALB REST NRXN1 MTDH EP300 BRD4 HNRNPU	1.55e-03	1430	26	7	GO:0044093
GeneOntologyBiologicalProcess	response to corticosteroid	REST EP300 HNRNPU	1.59e-03	185	26	3	GO:0031960
GeneOntologyBiologicalProcess	T-helper 17 cell differentiation	EP300 BRD4	1.60e-03	47	26	2	GO:0072539
GeneOntologyBiologicalProcess	regulation of T-helper 17 type immune response	EP300 BRD4	1.60e-03	47	26	2	GO:2000316
GeneOntologyBiologicalProcess	organelle localization	BCCIP RALB NRXN1 PCLO HNRNPU	1.64e-03	703	26	5	GO:0051640
GeneOntologyBiologicalProcess	secretion by cell	RALB NRXN3 REST NRXN1 EP300 PCLO	1.76e-03	1064	26	6	GO:0032940
GeneOntologyBiologicalProcess	regulation of autophagosome assembly	RALB FEZ2	1.80e-03	50	26	2	GO:2000785
GeneOntologyBiologicalProcess	signal release from synapse	NRXN3 NRXN1 PCLO	1.84e-03	195	26	3	GO:0099643
GeneOntologyBiologicalProcess	neurotransmitter secretion	NRXN3 NRXN1 PCLO	1.84e-03	195	26	3	GO:0007269
GeneOntologyBiologicalProcess	positive T cell selection	EP300 BRD4	2.02e-03	53	26	2	GO:0043368
GeneOntologyBiologicalProcess	regulation of cell fate commitment	EP300 BRD4	2.02e-03	53	26	2	GO:0010453
GeneOntologyBiologicalProcess	chromatin remodeling	PWWP2A REST EP300 BRD4 HNRNPU	2.07e-03	741	26	5	GO:0006338
GeneOntologyBiologicalProcess	positive regulation of transcription elongation by RNA polymerase II	PWWP2A BRD4	2.10e-03	54	26	2	GO:0032968
GeneOntologyBiologicalProcess	cell morphogenesis involved in neuron differentiation	NRXN3 REST NRXN1 FEZ2 EP300	2.16e-03	748	26	5	GO:0048667
GeneOntologyBiologicalProcess	response to dexamethasone	EP300 HNRNPU	2.18e-03	55	26	2	GO:0071548
GeneOntologyBiologicalProcess	regulation of T-helper cell differentiation	EP300 BRD4	2.34e-03	57	26	2	GO:0045622
GeneOntologyBiologicalProcess	postsynaptic density organization	NRXN3 NRXN1	2.42e-03	58	26	2	GO:0097106
GeneOntologyBiologicalProcess	positive regulation of CD4-positive, alpha-beta T cell activation	EP300 BRD4	2.42e-03	58	26	2	GO:2000516
GeneOntologyBiologicalProcess	regulation of alternative mRNA splicing, via spliceosome	REST HNRNPU	2.50e-03	59	26	2	GO:0000381
GeneOntologyBiologicalProcess	positive regulation of cell differentiation	ZNF609 REST PA2G4 EP300 BRD4 HNRNPU	2.50e-03	1141	26	6	GO:0045597
GeneOntologyBiologicalProcess	chromosome segregation	BCCIP CENPS BRD4 HNRNPU	2.57e-03	465	26	4	GO:0007059
GeneOntologyBiologicalProcess	presynapse assembly	NRXN1 PCLO	2.59e-03	60	26	2	GO:0099054
GeneOntologyBiologicalProcess	cardiocyte differentiation	REST EP300 HNRNPU	2.63e-03	221	26	3	GO:0035051
GeneOntologyBiologicalProcess	export from cell	RALB NRXN3 REST NRXN1 EP300 PCLO	2.64e-03	1153	26	6	GO:0140352
GeneOntologyBiologicalProcess	regulation of vacuole organization	RALB FEZ2	2.67e-03	61	26	2	GO:0044088
GeneOntologyBiologicalProcess	positive regulation of DNA-templated transcription, elongation	PWWP2A BRD4	2.76e-03	62	26	2	GO:0032786
GeneOntologyBiologicalProcess	regulation of T cell differentiation	ZNF609 EP300 BRD4	2.80e-03	226	26	3	GO:0045580
GeneOntologyBiologicalProcess	T-helper 17 type immune response	EP300 BRD4	2.94e-03	64	26	2	GO:0072538
GeneOntologyCellularComponent	nuclear cyclin-dependent protein kinase holoenzyme complex	BCCIP BRD4	2.43e-04	18	27	2	GO:0019908
GeneOntologyCellularComponent	inhibitory synapse	NRXN1 PCLO	7.30e-04	31	27	2	GO:0060077
GeneOntologyCellularComponent	presynaptic active zone	NRXN3 NRXN1 PCLO	7.80e-04	141	27	3	GO:0048786
GeneOntologyCellularComponent	GABA-ergic synapse	NRXN3 NRXN1 PCLO	1.21e-03	164	27	3	GO:0098982
Domain	Syndecan/Neurexin_dom	NRXN3 NRXN1	4.21e-05	7	27	2	IPR027789
Domain	Syndecan	NRXN3 NRXN1	4.21e-05	7	27	2	PF01034
Domain	Neurexin-like	NRXN3 NRXN1	1.81e-04	14	27	2	IPR003585
Domain	4.1m	NRXN3 NRXN1	1.81e-04	14	27	2	SM00294
Domain	Bromodomain_CS	EP300 BRD4	6.40e-04	26	27	2	IPR018359
Domain	BROMODOMAIN_1	EP300 BRD4	1.30e-03	37	27	2	PS00633
Domain	LAM_G_DOMAIN	NRXN3 NRXN1	1.37e-03	38	27	2	PS50025
Domain	Bromodomain	EP300 BRD4	1.37e-03	38	27	2	PF00439
Domain	Laminin_G_2	NRXN3 NRXN1	1.52e-03	40	27	2	PF02210
Domain	BROMODOMAIN_2	EP300 BRD4	1.59e-03	41	27	2	PS50014
Domain	BROMO	EP300 BRD4	1.67e-03	42	27	2	SM00297
Domain	Bromodomain	EP300 BRD4	1.67e-03	42	27	2	IPR001487
Domain	-	EP300 BRD4	1.67e-03	42	27	2	1.20.920.10
Domain	LamG	NRXN3 NRXN1	1.83e-03	44	27	2	SM00282
Domain	Laminin_G	NRXN3 NRXN1	3.16e-03	58	27	2	IPR001791
Domain	ConA-like_dom	NRXN3 NRXN1 HNRNPU	3.78e-03	219	27	3	IPR013320
Domain	-	NRXN3 NRXN1	8.27e-03	95	27	2	2.60.120.200
Domain	ASX_HYDROXYL	NRXN3 NRXN1	9.13e-03	100	27	2	PS00010
Domain	EGF-type_Asp/Asn_hydroxyl_site	NRXN3 NRXN1	1.02e-02	106	27	2	IPR000152
Domain	EGF	NRXN3 NRXN1	1.42e-02	126	27	2	PF00008
Pubmed	H4K20me0 recognition by BRCA1-BARD1 directs homologous recombination to sister chromatids.	PWWP2A MBTD1 CENPS ISG20L2 ZNF609 REST MTDH EP300 MACO1 BRD4 KTN1 HNRNPU	6.93e-11	1294	27	12	30804502
Pubmed	Association of a polymorphism in the NRXN3 gene with the degree of smoking in schizophrenia: a preliminary study.	NRXN3 NRXN1	5.80e-07	2	27	2	19658047
Pubmed	Neurexin-3 subsynaptic densities are spatially distinct from Neurexin-1 and essential for excitatory synapse nanoscale organization in the hippocampus.	NRXN3 NRXN1	5.80e-07	2	27	2	37543682
Pubmed	Neurexin I alpha is a major alpha-latrotoxin receptor that cooperates in alpha-latrotoxin action.	NRXN3 NRXN1	5.80e-07	2	27	2	9430716
Pubmed	LYRIC/AEG-1 overexpression modulates BCCIPalpha protein levels in prostate tumor cells.	BCCIP MTDH	5.80e-07	2	27	2	18440304
Pubmed	Scaffold/matrix attachment region elements interact with a p300-scaffold attachment factor A complex and are bound by acetylated nucleosomes.	EP300 HNRNPU	5.80e-07	2	27	2	11909954
Pubmed	In-Depth In Vivo Crosslinking in Minutes by a Compact, Membrane-Permeable, and Alkynyl-Enrichable Crosslinker.	CYLC1 RALB ISG20L2 NRXN3 NRXN1 MTDH PCLO KTN1 HNRNPU	8.41e-07	1442	27	9	35575683
Pubmed	The E3 ubiquitin ligase HECTD1 contributes to cell proliferation through an effect on mitosis.	ISG20L2 KIN PA2G4 MTDH FKBP3 KTN1 HNRNPU	1.39e-06	759	27	7	35915203
Pubmed	Endogenous β-neurexins on axons and within synapses show regulated dynamic behavior.	NRXN3 NRXN1	1.74e-06	3	27	2	34133920
Pubmed	Conditional Knockout of Neurexins Alters the Contribution of Calcium Channel Subtypes to Presynaptic Ca2+ Influx.	NRXN3 NRXN1	1.74e-06	3	27	2	38891114
Pubmed	Structure and evolution of neurexin genes: insight into the mechanism of alternative splicing.	NRXN3 NRXN1	1.74e-06	3	27	2	12036300
Pubmed	β-Neurexins Control Neural Circuits by Regulating Synaptic Endocannabinoid Signaling.	NRXN3 NRXN1	1.74e-06	3	27	2	26213384
Pubmed	Neurexin gene family variants as risk factors for autism spectrum disorder.	NRXN3 NRXN1	1.74e-06	3	27	2	29045040
Pubmed	Alternative Splicing of Presynaptic Neurexins Differentially Controls Postsynaptic NMDA and AMPA Receptor Responses.	NRXN3 NRXN1	1.74e-06	3	27	2	31005376
Pubmed	Structural and functional characterization of the IgSF21-neurexin2α complex and its related signaling pathways in the regulation of inhibitory synapse organization.	NRXN3 NRXN1	1.74e-06	3	27	2	38571813
Pubmed	Deletion of β-Neurexins in Mice Alters the Distribution of Dense-Core Vesicles in Presynapses of Hippocampal and Cerebellar Neurons.	NRXN3 NRXN1	1.74e-06	3	27	2	35173587
Pubmed	Brd4-p300 inhibition downregulates Nox4 and accelerates lung fibrosis resolution in aged mice.	EP300 BRD4	1.74e-06	3	27	2	32544088
Pubmed	The within-subject application of diffusion tensor MRI and CLARITY reveals brain structural changes in Nrxn2 deletion mice.	NRXN3 NRXN1	1.74e-06	3	27	2	30858964
Pubmed	Neurexins are differentially expressed in the embryonic nervous system of mice.	NRXN3 NRXN1	1.74e-06	3	27	2	7722633
Pubmed	Regulated Dynamic Trafficking of Neurexins Inside and Outside of Synaptic Terminals.	NRXN3 NRXN1	1.74e-06	3	27	2	26446217
Pubmed	Neurexins 1-3 Each Have a Distinct Pattern of Expression in the Early Developing Human Cerebral Cortex.	NRXN3 NRXN1	1.74e-06	3	27	2	28013231
Pubmed	Analysis of the human neurexin genes: alternative splicing and the generation of protein diversity.	NRXN3 NRXN1	1.74e-06	3	27	2	11944992
Pubmed	alpha-Neurexins are required for efficient transmitter release and synaptic homeostasis at the mouse neuromuscular junction.	NRXN3 NRXN1	1.74e-06	3	27	2	16406382
Pubmed	Alternative splicing of neurexins 1-3 is modulated by neuroinflammation in the prefrontal cortex of a murine model of multiple sclerosis.	NRXN3 NRXN1	1.74e-06	3	27	2	33058888
Pubmed	Important contribution of alpha-neurexins to Ca2+-triggered exocytosis of secretory granules.	NRXN3 NRXN1	1.74e-06	3	27	2	17035546
Pubmed	Neurexins: three genes and 1001 products.	NRXN3 NRXN1	1.74e-06	3	27	2	9448462
Pubmed	Deletion of α-neurexin II results in autism-related behaviors in mice.	NRXN3 NRXN1	1.74e-06	3	27	2	25423136
Pubmed	Ketamine Restores Thalamic-Prefrontal Cortex Functional Connectivity in a Mouse Model of Neurodevelopmental Disorder-Associated 2p16.3 Deletion.	NRXN3 NRXN1	1.74e-06	3	27	2	31812984
Pubmed	Promoter-bound p300 complexes facilitate post-mitotic transmission of transcriptional memory.	EP300 BRD4	1.74e-06	3	27	2	24945803
Pubmed	Astrocyte Elevated Gene 1 Interacts with Acetyltransferase p300 and c-Jun To Promote Tumor Aggressiveness.	MTDH EP300	1.74e-06	3	27	2	27956703
Pubmed	Oncogenesis by sequestration of CBP/p300 in transcriptionally inactive hyperacetylated chromatin domains.	EP300 BRD4	1.74e-06	3	27	2	20676058
Pubmed	KIF15 promotes human glioblastoma progression under the synergistic transactivation of REST and P300.	REST EP300	1.74e-06	3	27	2	39430242
Pubmed	Distinct Roles of Brd2 and Brd4 in Potentiating the Transcriptional Program for Th17 Cell Differentiation.	EP300 BRD4	1.74e-06	3	27	2	28262505
Pubmed	Postsynaptic N-methyl-D-aspartate receptor function requires alpha-neurexins.	NRXN3 NRXN1	3.48e-06	4	27	2	14983056
Pubmed	CASK: a novel dlg/PSD95 homolog with an N-terminal calmodulin-dependent protein kinase domain identified by interaction with neurexins.	NRXN3 NRXN1	3.48e-06	4	27	2	8786425
Pubmed	Brd4's Bromodomains Mediate Histone H3 Acetylation and Chromatin Remodeling in Pluripotent Cells through P300 and Brg1.	EP300 BRD4	3.48e-06	4	27	2	30428346
Pubmed	NSD3-NUT fusion oncoprotein in NUT midline carcinoma: implications for a novel oncogenic mechanism.	EP300 BRD4	3.48e-06	4	27	2	24875858
Pubmed	Deletion of alpha-neurexins does not cause a major impairment of axonal pathfinding or synapse formation.	NRXN3 NRXN1	3.48e-06	4	27	2	17347997
Pubmed	Neurexins cluster Ca2+ channels within the presynaptic active zone.	NRXN3 NRXN1	3.48e-06	4	27	2	32134527
Pubmed	Deorphanizing FAM19A proteins as pan-neurexin ligands with an unusual biosynthetic binding mechanism.	NRXN3 NRXN1	3.48e-06	4	27	2	32706374
Pubmed	Binding of the SARS-CoV-2 envelope E protein to human BRD4 is essential for infection.	EP300 BRD4	3.48e-06	4	27	2	35716662
Pubmed	Neurexins play a crucial role in cerebellar granule cell survival by organizing autocrine machinery for neurotrophins.	NRXN3 NRXN1	3.48e-06	4	27	2	35385735
Pubmed	Neurexins regulate presynaptic GABAB-receptors at central synapses.	NRXN3 NRXN1	3.48e-06	4	27	2	33888718
Pubmed	TNRC6 proteins modulate hepatitis C virus replication by spatially regulating the binding of miR-122/Ago2 complexes to viral RNA.	PA2G4 MTDH FKBP3 KTN1 HNRNPU	4.17e-06	317	27	5	30997501
Pubmed	Conditional Deletion of All Neurexins Defines Diversity of Essential Synaptic Organizer Functions for Neurexins.	NRXN3 NRXN1	5.80e-06	5	27	2	28472659
Pubmed	Concerted roles of LRRTM1 and SynCAM 1 in organizing prefrontal cortex synapses and cognitive functions.	NRXN3 NRXN1	5.80e-06	5	27	2	36709330
Pubmed	Neuroligins and neurexins link synaptic function to cognitive disease.	NRXN3 NRXN1	5.80e-06	5	27	2	18923512
Pubmed	Trans-synaptic interaction of GluRdelta2 and Neurexin through Cbln1 mediates synapse formation in the cerebellum.	NRXN3 NRXN1	5.80e-06	5	27	2	20537373
Pubmed	Distinct neurexin-cerebellin complexes control AMPA- and NMDA-receptor responses in a circuit-dependent manner.	NRXN3 NRXN1	5.80e-06	5	27	2	36205393
Pubmed	Acetylcholinesterase-transgenic mice display embryonic modulations in spinal cord choline acetyltransferase and neurexin Ibeta gene expression followed by late-onset neuromotor deterioration.	NRXN3 NRXN1	5.80e-06	5	27	2	9223334
Pubmed	The Nse5/6-like SIMC1-SLF2 complex localizes SMC5/6 to viral replication centers.	ZNF609 PA2G4 MTDH FKBP3 BRD4 KTN1 HNRNPU	6.28e-06	954	27	7	36373674
Pubmed	The Epigenetic Factor Landscape of Developing Neocortex Is Regulated by Transcription Factors Pax6→ Tbr2→ Tbr1.	MLLT3 MBTD1 REST EP300	6.47e-06	157	27	4	30186101
Pubmed	Structures, alternative splicing, and neurexin binding of multiple neuroligins.	NRXN3 NRXN1	8.69e-06	6	27	2	8576240
Pubmed	Presynaptic α2δ-2 Calcium Channel Subunits Regulate Postsynaptic GABAA Receptor Abundance and Axonal Wiring.	NRXN3 NRXN1	8.69e-06	6	27	2	30683685
Pubmed	Alpha-neurexins couple Ca2+ channels to synaptic vesicle exocytosis.	NRXN3 NRXN1	8.69e-06	6	27	2	12827191
Pubmed	Synapse formation regulated by protein tyrosine phosphatase receptor T through interaction with cell adhesion molecules and Fyn.	NRXN3 NRXN1	8.69e-06	6	27	2	19816407
Pubmed	Glycosylation of Cblns attenuates their receptor binding.	NRXN3 NRXN1	1.22e-05	7	27	2	29782851
Pubmed	Neurexophilin binding to alpha-neurexins. A single LNS domain functions as an independently folding ligand-binding unit.	NRXN3 NRXN1	1.22e-05	7	27	2	9856994
Pubmed	Identification and functional characterization of transcriptional activators in human cells.	MBTD1 ZNF609 EP300 BRD4 PCLO	1.26e-05	398	27	5	35016035
Pubmed	GluD1 is a signal transduction device disguised as an ionotropic receptor.	NRXN3 NRXN1	1.62e-05	8	27	2	34135511
Pubmed	Neuroligin-1 Signaling Controls LTP and NMDA Receptors by Distinct Molecular Pathways.	NRXN3 NRXN1	1.62e-05	8	27	2	30871858
Pubmed	The methyltransferase SMYD3 mediates the recruitment of transcriptional cofactors at the myostatin and c-Met genes and regulates skeletal muscle atrophy.	EP300 BRD4	1.62e-05	8	27	2	23752591
Pubmed	Combinatorial expression of neurexins and LAR-type phosphotyrosine phosphatase receptors instructs assembly of a cerebellar circuit.	NRXN3 NRXN1	1.62e-05	8	27	2	37591863
Pubmed	An antibody-based proximity labeling map reveals mechanisms of SARS-CoV-2 inhibition of antiviral immunity.	C1D BCCIP ZNF609 KIN MACO1 KTN1	1.74e-05	733	27	6	34672954
Pubmed	Reduced expression of neuropeptide genes in a genome-wide screen of a secretion-deficient mouse.	NRXN3 NRXN1 PCLO	1.93e-05	67	27	3	16987237
Pubmed	PDZ-domain-mediated interaction of the Eph-related receptor tyrosine kinase EphB3 and the ras-binding protein AF6 depends on the kinase activity of the receptor.	NRXN3 NRXN1	2.08e-05	9	27	2	9707552
Pubmed	Molecular self-avoidance in synaptic neurexin complexes.	NRXN3 NRXN1	2.08e-05	9	27	2	34919427
Pubmed	Human ALKBH4 interacts with proteins associated with transcription.	MLLT3 EP300	2.60e-05	10	27	2	23145062
Pubmed	HIV-1 Vif promotes the G₁- to S-phase cell-cycle transition.	BRD4 HNRNPU	2.60e-05	10	27	2	21149631
Pubmed	Wnt regulation: exploring Axin-Disheveled interactions and defining mechanisms by which the SCF E3 ubiquitin ligase is recruited to the destruction complex.	ISG20L2 PA2G4 MTDH FKBP3 KTN1 HNRNPU	3.03e-05	809	27	6	32129710
Pubmed	SPARCL1 Promotes Excitatory But Not Inhibitory Synapse Formation and Function Independent of Neurexins and Neuroligins.	NRXN3 NRXN1	3.18e-05	11	27	2	32973045
Pubmed	The contribution of rare and common variants in 30 genes to risk nicotine dependence.	NRXN3 NRXN1	5.25e-05	14	27	2	25450229
Pubmed	HDLBP Promotes Hepatocellular Carcinoma Proliferation and Sorafenib Resistance by Suppressing Trim71-dependent RAF1 Degradation.	C1D BCCIP ISG20L2 PA2G4 MTDH FKBP3 KTN1	6.46e-05	1371	27	7	36244648
Pubmed	Cohesin regulates tissue-specific expression by stabilizing highly occupied cis-regulatory modules.	REST EP300	6.92e-05	16	27	2	22780989
Pubmed	Prediction of the coding sequences of unidentified human genes. IX. The complete sequences of 100 new cDNA clones from brain which can code for large proteins in vitro.	NRXN3 NRXN1 PCLO	7.42e-05	105	27	3	9628581
Pubmed	LINC00240 in the 6p22.1 risk locus promotes gastric cancer progression through USP10-mediated DDX21 stabilization.	PA2G4 KTN1	7.84e-05	17	27	2	37072811
Pubmed	MEF2C regulates cortical inhibitory and excitatory synapses and behaviors relevant to neurodevelopmental disorders.	NRXN3 NRXN1	7.84e-05	17	27	2	27779093
Pubmed	Gain of Additional BIRC3 Protein Functions through 3'-UTR-Mediated Protein Complex Formation.	BCCIP PA2G4 MTDH FKBP3 PCLO KTN1 HNRNPU	8.24e-05	1425	27	7	30948266
Pubmed	The leukemogenic AF4-MLL fusion protein causes P-TEFb kinase activation and altered epigenetic signatures.	MLLT3 BRD4	8.81e-05	18	27	2	21030982
Pubmed	Acetylation-regulated interaction between p53 and SET reveals a widespread regulatory mode.	EP300 BRD4	9.84e-05	19	27	2	27626385
Pubmed	Lost in transcription: molecular mechanisms that control HIV latency.	MLLT3 BRD4	9.84e-05	19	27	2	23518577
Pubmed	STING-Mediated IFI16 Degradation Negatively Controls Type I Interferon Production.	ISG20L2 MTDH KTN1 HNRNPU	9.95e-05	316	27	4	31665637
Pubmed	Acetylation of ELF5 suppresses breast cancer progression by promoting its degradation and targeting CCND1.	BCCIP PA2G4 MTDH EP300 HNRNPU	1.32e-04	653	27	5	33742100
Pubmed	Cbln1 regulates axon growth and guidance in multiple neural regions.	NRXN3 NRXN1	1.33e-04	22	27	2	36395107
Pubmed	Overlapping Activities of Two Neuronal Splicing Factors Switch the GABA Effect from Excitatory to Inhibitory by Regulating REST.	NRXN3 REST NRXN1	1.34e-04	128	27	3	30995482
Pubmed	New insights into the control of HIV-1 transcription: when Tat meets the 7SK snRNP and super elongation complex (SEC).	MLLT3 BRD4	1.45e-04	23	27	2	21360054
Pubmed	MECP2 directly interacts with RNA polymerase II to modulate transcription in human neurons.	KIN NRXN1 MTDH FKBP3 BRD4 HNRNPU	1.51e-04	1082	27	6	38697112
Pubmed	PRISMA and BioID disclose a motifs-based interactome of the intrinsically disordered transcription factor C/EBPα.	ZNF609 PA2G4 FKBP3 EP300 BRD4 HNRNPU	1.68e-04	1103	27	6	34189442
Pubmed	Matrix-screening reveals a vast potential for direct protein-protein interactions among RNA binding proteins.	FEZ2 PA2G4 FKBP3 BRD4 HNRNPU	2.11e-04	723	27	5	34133714
Pubmed	A Degradation Motif in STAU1 Defines a Novel Family of Proteins Involved in Inflammation.	ZNF609 KIN MTDH FKBP3 KTN1	2.13e-04	724	27	5	36232890
Pubmed	Prohibitin 1 regulates tumor cell apoptosis via the interaction with X-linked inhibitor of apoptosis protein.	KIN PA2G4 MTDH KTN1 HNRNPU	2.14e-04	725	27	5	27025967
Pubmed	Differential expression of paralog RNA binding proteins establishes a dynamic splicing program required for normal cerebral cortex development.	NRXN3 NRXN1	2.17e-04	28	27	2	38324473
Pubmed	Characterizing ZC3H18, a Multi-domain Protein at the Interface of RNA Production and Destruction Decisions.	C1D ISG20L2 PA2G4 MTDH HNRNPU	2.23e-04	731	27	5	29298432
Pubmed	Therapeutic targeting of the USP2-E2F4 axis inhibits autophagic machinery essential for zinc homeostasis in cancer progression.	PA2G4 FKBP3 BRD4 KTN1	2.52e-04	403	27	4	35253629
Pubmed	miR-218 Promotes Dopaminergic Differentiation and Controls Neuron Excitability and Neurotransmitter Release through the Regulation of a Synaptic-Related Genes Network.	NRXN1 PCLO	2.66e-04	31	27	2	37816598
Pubmed	Exploring an Alternative Cysteine-Reactive Chemistry to Enable Proteome-Wide PPI Analysis by Cross-Linking Mass Spectrometry.	BCCIP PA2G4 KTN1 HNRNPU	2.72e-04	411	27	4	36652389
Pubmed	Comparative Proteomics and Interactome Analysis of the SARS-CoV-2 Nucleocapsid Protein in Human and Bat Cell Lines.	PA2G4 MTDH HNRNPU	2.97e-04	168	27	3	39066279
Pubmed	Multiplexed barcoded CRISPR-Cas9 screening enabled by CombiGEM.	EP300 BRD4	3.02e-04	33	27	2	26864203
Pubmed	Human variation in alcohol response is influenced by variation in neuronal signaling genes.	NRXN1 FEZ2 PCLO	3.13e-04	171	27	3	20201926
Pubmed	DBC1, p300, HDAC3, and Siah1 coordinately regulate ELL stability and function for expression of its target genes.	MLLT3 EP300	3.21e-04	34	27	2	32152128
Interaction	RPL19 interactions	BCCIP ISG20L2 REST KIN PA2G4 MTDH FKBP3 BRD4 KTN1 HNRNPU	4.89e-09	638	27	10	int:RPL19
Interaction	BCCIP interactions	BCCIP MTDH EP300 BRD4 HNRNPU	1.89e-06	157	27	5	int:BCCIP
Interaction	RBM8A interactions	BCCIP PA2G4 MTDH FKBP3 BRD4 KTN1 HNRNPU	2.22e-06	473	27	7	int:RBM8A
Interaction	H2BC12 interactions	CYLC1 PWWP2A RALB MTDH BRD4 PCLO	3.54e-06	322	27	6	int:H2BC12
Interaction	PSPC1 interactions	ISG20L2 PA2G4 MTDH EP300 BRD4 KTN1 HNRNPU	3.89e-06	515	27	7	int:PSPC1
Interaction	RPL4 interactions	BCCIP REST KIN PA2G4 MTDH BRD4 KTN1 HNRNPU	4.81e-06	764	27	8	int:RPL4
Interaction	RALY interactions	BCCIP REST MTDH EP300 BRD4 HNRNPU	6.30e-06	356	27	6	int:RALY
Interaction	PHB1 interactions	RALB KIN NRXN1 PA2G4 MTDH EP300 BRD4 KTN1 HNRNPU	9.43e-06	1123	27	9	int:PHB1
Interaction	RTRAF interactions	FEZ2 FKBP3 EP300 BRD4 HNRNPU	1.03e-05	222	27	5	int:RTRAF
Interaction	HDAC2 interactions	PWWP2A ZNF609 REST PA2G4 FKBP3 EP300 BRD4 HNRNPU	1.20e-05	865	27	8	int:HDAC2
Interaction	RPL12 interactions	C1D REST KIN PA2G4 BRD4 HNRNPU	1.26e-05	402	27	6	int:RPL12
Interaction	MRGBP interactions	MBTD1 REST BRD4 HNRNPU	1.29e-05	109	27	4	int:MRGBP
Interaction	HMGA1 interactions	PWWP2A REST PA2G4 FKBP3 BRD4 PCLO	1.59e-05	419	27	6	int:HMGA1
Interaction	NELFB interactions	PA2G4 FKBP3 BRD4 HNRNPU	1.60e-05	115	27	4	int:NELFB
Interaction	NPM1 interactions	BCCIP ISG20L2 REST PA2G4 MTDH EP300 BRD4 KTN1 HNRNPU	1.62e-05	1201	27	9	int:NPM1
Interaction	FBXW2 interactions	REST MTDH EP300	1.75e-05	38	27	3	int:FBXW2
Interaction	MTREX interactions	C1D MTDH EP300 BRD4 HNRNPU	2.28e-05	262	27	5	int:MTREX
Interaction	RPL18A interactions	REST KIN PA2G4 MTDH BRD4 HNRNPU	2.29e-05	447	27	6	int:RPL18A
Interaction	CTCF interactions	PA2G4 MTDH EP300 BRD4 KTN1 HNRNPU	2.73e-05	461	27	6	int:CTCF
Interaction	H2BC21 interactions	CYLC1 PWWP2A REST EP300 BRD4 PCLO HNRNPU	2.76e-05	696	27	7	int:H2BC21
Interaction	LOC102724334 interactions	CYLC1 C1D PWWP2A PCLO	2.91e-05	134	27	4	int:LOC102724334
Interaction	ASCL1 interactions	REST EP300 BRD4	2.93e-05	45	27	3	int:ASCL1
Interaction	HECTD1 interactions	ISG20L2 KIN PA2G4 MTDH FKBP3 EP300 KTN1 HNRNPU	3.04e-05	984	27	8	int:HECTD1
Interaction	RPL3 interactions	ISG20L2 REST KIN PA2G4 MTDH BRD4 HNRNPU	3.49e-05	722	27	7	int:RPL3
Interaction	MCM6 interactions	MLLT3 MTDH EP300 BRD4 HNRNPU	3.53e-05	287	27	5	int:MCM6
Interaction	SUDS3 interactions	PWWP2A ZNF609 EP300 BRD4	3.56e-05	141	27	4	int:SUDS3
Interaction	H2BC15 interactions	CYLC1 BCCIP REST PCLO	3.86e-05	144	27	4	int:H2BC15
Interaction	RPL18 interactions	REST KIN PA2G4 MTDH BRD4 HNRNPU	4.91e-05	512	27	6	int:RPL18
Interaction	TOP2A interactions	CYLC1 MTDH EP300 BRD4 KTN1 HNRNPU	5.35e-05	520	27	6	int:TOP2A
Interaction	EMD interactions	BCCIP MTDH EP300 MACO1 BRD4 KTN1 HNRNPU	6.14e-05	789	27	7	int:EMD
Interaction	SRP72 interactions	PA2G4 MTDH EP300 KTN1 HNRNPU	7.16e-05	333	27	5	int:SRP72
Interaction	ABCA12 interactions	MTDH BRD4	7.73e-05	10	27	2	int:ABCA12
Interaction	TULP3 interactions	BCCIP RALB MLLT3 MBTD1 EP300	8.57e-05	346	27	5	int:TULP3
Interaction	SND1 interactions	PA2G4 MTDH EP300 BRD4 HNRNPU	8.69e-05	347	27	5	int:SND1
Interaction	SAP130 interactions	BCCIP PWWP2A BRD4 HNRNPU	9.40e-05	181	27	4	int:SAP130
Interaction	H2BC26 interactions	MBTD1 REST BRD4 PCLO	9.81e-05	183	27	4	int:H2BC26
Interaction	RPL21 interactions	REST NRXN1 PA2G4 BRD4 HNRNPU	9.93e-05	357	27	5	int:RPL21
Interaction	DDX47 interactions	REST EP300 BRD4 HNRNPU	1.04e-04	186	27	4	int:DDX47
Interaction	H2BC11 interactions	CYLC1 REST BRD4 PCLO	1.04e-04	186	27	4	int:H2BC11
Interaction	API5 interactions	ZNF609 EP300 BRD4 HNRNPU	1.09e-04	188	27	4	int:API5
Interaction	RNF2 interactions	MLLT3 MBTD1 REST MTDH BRD4 PCLO HNRNPU	1.10e-04	866	27	7	int:RNF2
Interaction	RPS6 interactions	BCCIP ISG20L2 REST PA2G4 BRD4 PCLO HNRNPU	1.17e-04	874	27	7	int:RPS6
Interaction	RPL5 interactions	REST PA2G4 MTDH BRD4 KTN1 HNRNPU	1.24e-04	606	27	6	int:RPL5
Interaction	STMN1 interactions	NRXN1 FKBP3 EP300 BRD4	1.25e-04	195	27	4	int:STMN1
Interaction	TARS1 interactions	REST FKBP3 BRD4 HNRNPU	1.25e-04	195	27	4	int:TARS1
Interaction	SIN3A interactions	PWWP2A REST PA2G4 EP300 BRD4	1.33e-04	380	27	5	int:SIN3A
Interaction	MRTO4 interactions	ISG20L2 MTDH EP300 HNRNPU	1.38e-04	200	27	4	int:MRTO4
Interaction	ABCF1 interactions	FKBP3 EP300 BRD4 HNRNPU	1.41e-04	201	27	4	int:ABCF1
Interaction	GNL2 interactions	C1D ISG20L2 MTDH BRD4 HNRNPU	1.43e-04	386	27	5	int:GNL2
Interaction	GRIA2 interactions	REST NRXN1 MTDH HNRNPU	1.46e-04	203	27	4	int:GRIA2
Interaction	PSIP1 interactions	REST MTDH EP300 BRD4	1.52e-04	205	27	4	int:PSIP1
Interaction	ITGAL interactions	EP300 HNRNPU	1.56e-04	14	27	2	int:ITGAL
Interaction	ELL interactions	MLLT3 EP300 HNRNPU	1.64e-04	80	27	3	int:ELL
Interaction	FBL interactions	REST MTDH FKBP3 BRD4 KTN1 HNRNPU	1.66e-04	639	27	6	int:FBL
Interaction	PCAT1 interactions	EP300 PCLO	1.80e-04	15	27	2	int:PCAT1
Interaction	CAPN1 interactions	BCCIP EP300 BRD4 KTN1	1.82e-04	215	27	4	int:CAPN1
Interaction	TAF15 interactions	ZNF609 REST EP300 BRD4 HNRNPU	1.85e-04	408	27	5	int:TAF15
Interaction	RPL11 interactions	REST PA2G4 MTDH BRD4 KTN1 HNRNPU	1.86e-04	652	27	6	int:RPL11
Interaction	MDM2 interactions	REST PA2G4 MTDH FKBP3 EP300 HNRNPU	1.95e-04	658	27	6	int:MDM2
Interaction	RPLP0 interactions	REST KIN PA2G4 MTDH BRD4 HNRNPU	1.98e-04	660	27	6	int:RPLP0
Interaction	DHX9 interactions	REST PA2G4 MTDH EP300 BRD4 HNRNPU	2.01e-04	662	27	6	int:DHX9
Interaction	ALYREF interactions	REST KIN EP300 BRD4 HNRNPU	2.03e-04	416	27	5	int:ALYREF
Interaction	LINC00240 interactions	PA2G4 KTN1	2.05e-04	16	27	2	int:LINC00240
Interaction	ERG interactions	ZNF609 EP300 BRD4 HNRNPU	2.10e-04	223	27	4	int:ERG
Interaction	KRT18 interactions	FKBP3 EP300 MACO1 BRD4 HNRNPU	2.10e-04	419	27	5	int:KRT18
Interaction	SRSF9 interactions	MBTD1 REST EP300 BRD4	2.13e-04	224	27	4	int:SRSF9
Interaction	RFC4 interactions	FKBP3 EP300 BRD4 HNRNPU	2.24e-04	227	27	4	int:RFC4
Interaction	DDX17 interactions	REST KIN EP300 BRD4 HNRNPU	2.27e-04	426	27	5	int:DDX17
Interaction	RPL27 interactions	REST PA2G4 EP300 BRD4 HNRNPU	2.39e-04	431	27	5	int:RPL27
Interaction	RERE interactions	ZNF609 REST EP300	2.57e-04	93	27	3	int:RERE
Interaction	SMC5 interactions	ZNF609 PA2G4 MTDH FKBP3 BRD4 KTN1 HNRNPU	2.69e-04	1000	27	7	int:SMC5
Interaction	H2BC9 interactions	CYLC1 PWWP2A REST BRD4 PCLO	2.80e-04	446	27	5	int:H2BC9
Interaction	RACK1 interactions	ISG20L2 PA2G4 MTDH EP300 BRD4 KTN1	2.81e-04	704	27	6	int:RACK1
Interaction	SOX9 interactions	ZNF609 EP300 BRD4	2.91e-04	97	27	3	int:SOX9
Interaction	PAX4 interactions	NRXN3 HNRNPU	2.91e-04	19	27	2	int:PAX4
Interaction	IFI16 interactions	ISG20L2 MTDH EP300 BRD4 KTN1 HNRNPU	3.03e-04	714	27	6	int:IFI16
Interaction	SUB1 interactions	REST ARHGAP20 EP300 BRD4	3.10e-04	247	27	4	int:SUB1
Interaction	EIF2S2 interactions	PA2G4 MTDH BRD4 KTN1	3.10e-04	247	27	4	int:EIF2S2
Interaction	CBX8 interactions	MLLT3 EP300 BRD4 HNRNPU	3.19e-04	249	27	4	int:CBX8
Interaction	RPS16 interactions	REST PA2G4 MTDH BRD4 KTN1 HNRNPU	3.27e-04	724	27	6	int:RPS16
Interaction	EEF1G interactions	MTDH EP300 BRD4 KTN1 HNRNPU	3.33e-04	463	27	5	int:EEF1G
Interaction	RPS7 interactions	REST KIN NRXN1 BRD4 HNRNPU	3.43e-04	466	27	5	int:RPS7
Interaction	H1-0 interactions	PWWP2A REST BRD4 HNRNPU	3.55e-04	256	27	4	int:H1-0
Interaction	SYT4 interactions	REST NRXN1	3.57e-04	21	27	2	int:SYT4
Interaction	DDX50 interactions	MTDH EP300 BRD4 HNRNPU	3.60e-04	257	27	4	int:DDX50
Interaction	SF3A1 interactions	ARHGAP20 PA2G4 EP300 BRD4 HNRNPU	3.60e-04	471	27	5	int:SF3A1
Interaction	DHCR7 interactions	MTDH EP300 PCLO KTN1	3.65e-04	258	27	4	int:DHCR7
Interaction	HMGB2 interactions	BCCIP EP300 BRD4 KTN1	3.65e-04	258	27	4	int:HMGB2
Interaction	H2BC4 interactions	PWWP2A RALB MTDH BRD4	3.71e-04	259	27	4	int:H2BC4
Interaction	SRPK1 interactions	MTDH FKBP3 EP300 BRD4 HNRNPU	3.82e-04	477	27	5	int:SRPK1
Interaction	IRF2 interactions	PA2G4 MTDH EP300	3.88e-04	107	27	3	int:IRF2
Interaction	NLGN1 interactions	NRXN3 NRXN1	3.93e-04	22	27	2	int:NLGN1
Interaction	EIF3C interactions	EP300 BRD4 PCLO HNRNPU	3.93e-04	263	27	4	int:EIF3C
Interaction	YBX1 interactions	REST PA2G4 MTDH FKBP3 EP300 HNRNPU	4.00e-04	752	27	6	int:YBX1
Interaction	HNRNPA2B1 interactions	PA2G4 MTDH FKBP3 EP300 BRD4 HNRNPU	4.06e-04	754	27	6	int:HNRNPA2B1
Interaction	TMPO interactions	MTDH EP300 MACO1 BRD4 KTN1 HNRNPU	4.29e-04	762	27	6	int:TMPO
Interaction	CEBPB interactions	MLLT3 PA2G4 MTDH FKBP3 EP300 BRD4 KTN1 HNRNPU	4.39e-04	1443	27	8	int:CEBPB
Interaction	RPL28 interactions	REST PA2G4 KIAA0232 BRD4 HNRNPU	4.48e-04	494	27	5	int:RPL28
Interaction	EFTUD2 interactions	RALB KIN PA2G4 MTDH FKBP3 BRD4 KTN1 HNRNPU	4.51e-04	1449	27	8	int:EFTUD2
Interaction	SF3A2 interactions	REST EP300 BRD4 HNRNPU	4.52e-04	273	27	4	int:SF3A2
Coexpression	LEE_BMP2_TARGETS_DN	BCCIP MLLT3 CENPS ISG20L2 ARHGAP20 PA2G4 FKBP3	2.75e-05	904	27	7	M2325
Coexpression	LEE_BMP2_TARGETS_DN	BCCIP MLLT3 CENPS ISG20L2 ARHGAP20 PA2G4 FKBP3	3.12e-05	922	27	7	MM1068
Coexpression	GSE12392_CD8A_POS_VS_NEG_SPLEEN_IFNB_KO_DC_DN	RALB MLLT3 FKBP3 BRD4	5.03e-05	200	27	4	M7134
Coexpression	GSE39820_CTRL_VS_TGFBETA3_IL6_CD4_TCELL_UP	ISG20L2 MTDH FKBP3 HNRNPU	5.03e-05	200	27	4	M5610
Coexpression	DIAZ_CHRONIC_MYELOGENOUS_LEUKEMIA_UP	C1D RALB MLLT3 CENPS REST FEZ2 FKBP3 KTN1	5.76e-05	1399	27	8	M535
Coexpression	SCHLOSSER_SERUM_RESPONSE_DN	C1D ISG20L2 KIN MTDH EP300 KTN1	6.77e-05	705	27	6	M1410
Coexpression	SCHAEFFER_PROSTATE_DEVELOPMENT_6HR_DN	MLLT3 REST MACO1 BRD4 HNRNPU	1.03e-04	467	27	5	M1347
Coexpression	SCHAEFFER_PROSTATE_DEVELOPMENT_6HR_DN	MLLT3 REST MACO1 BRD4 HNRNPU	1.21e-04	484	27	5	MM999
CoexpressionAtlas	FacebaseRNAseq_e8.5_Hind Brain Neural Epithelium_top-relative-expression-ranked_2500_k-means-cluster#3	MLLT3 FKBP3 MACO1 PCLO KTN1 HNRNPU	3.61e-05	532	26	6	Facebase_RNAseq_e8.5_Hind Brain Neural Epithelium_2500_K3
CoexpressionAtlas	FacebaseRNAseq_e10.5_Neural Epithelium Overlying Central Eminence_top-relative-expression-ranked_2500_k-means-cluster#3	MLLT3 ZNF609 NRXN3 NRXN1 PCLO KTN1 HNRNPU	7.41e-05	893	26	7	Facebase_RNAseq_e10.5_Neural Epithelium Overlying Central Eminence_2500_K3
CoexpressionAtlas	FacebaseRNAseq_e10.5_Maxillary Arch_top-relative-expression-ranked_2500_k-means-cluster#5	C1D MBTD1 REST KIN KTN1 HNRNPU	9.15e-05	629	26	6	Facebase_RNAseq_e10.5_Maxillary Arch_2500_K5
CoexpressionAtlas	FacebaseRNAseq_e8.5_Hind Brain Neural Epithelium_top-relative-expression-ranked_1000_k-means-cluster#5	MLLT3 PCLO KTN1 HNRNPU	1.05e-04	204	26	4	Facebase_RNAseq_e8.5_Hind Brain Neural Epithelium_1000_K5
CoexpressionAtlas	FacebaseRNAseq_e9.5_Olfactory Placode_top-relative-expression-ranked_1000_k-means-cluster#2	NRXN3 NRXN1 PCLO KTN1	1.17e-04	210	26	4	Facebase_RNAseq_e9.5_Olfactory Placode_1000_K2
CoexpressionAtlas	facebase_RNAseq_e10.5_NeuroEpith_central_2500_K4	MLLT3 ZNF609 KIN NRXN1 MTDH BRD4 KTN1 HNRNPU	1.61e-04	1370	26	8	facebase_RNAseq_e10.5_NeuroEpith_central_2500_K4
CoexpressionAtlas	facebase_RNAseq_e10.5_Emin_LatNas_2500	C1D NRXN3 KIN MTDH FKBP3 BRD4 KTN1 HNRNPU	2.49e-04	1459	26	8	facebase_RNAseq_e10.5_Emin_LatNas_2500
CoexpressionAtlas	FacebaseRNAseq_e8.5_Hind Brain Neural Epithelium_top-relative-expression-ranked_500_k-means-cluster#4	MLLT3 KTN1 HNRNPU	4.58e-04	124	26	3	Facebase_RNAseq_e8.5_Hind Brain Neural Epithelium_500_K4
CoexpressionAtlas	DevelopingGonad_e12.5_ovary_emap-28876_k-means-cluster#1_top-relative-expression-ranked_1000	PWWP2A MBTD1 MACO1	5.26e-04	130	26	3	gudmap_developingGonad_e12.5_ovary_k1_1000
CoexpressionAtlas	FacebaseRNAseq_e9.5_Mandibular Arch_top-relative-expression-ranked_2500_k-means-cluster#2	C1D MBTD1 REST KIN MTDH	5.38e-04	564	26	5	Facebase_RNAseq_e9.5_Mandibular Arch_2500_K2
CoexpressionAtlas	facebase_RNAseq_e10.5_Emin_LatNas_2500_K3	C1D KIN MTDH FKBP3 BRD4 KTN1 HNRNPU	6.09e-04	1257	26	7	facebase_RNAseq_e10.5_Emin_LatNas_2500_K3
ToppCell	facs-Brain_Non-Myeloid-Cerebellum-3m-Neuronal-interneuron\|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation	PWWP2A ZNF609 NRXN3 CNGA1	3.62e-06	175	27	4	65571d775d26a40e979dbf290a8e4320c0d9fb3f
ToppCell	facs-Brain_Non-Myeloid-Cerebellum-3m-Neuronal-nan\|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation	PWWP2A ZNF609 NRXN3 PCLO	4.05e-06	180	27	4	f6a2208960d0df1500c974cc44c3c054cd7475a9
ToppCell	Brain_organoid-organoid_Paulsen_bioRxiv-6_mon-Neuronal\|6_mon / Sample Type, Dataset, Time_group, and Cell type.	MLLT3 NRXN3 NRXN1 PCLO	5.90e-06	198	27	4	076c862f2a723f0361749377561cae902068b1a0
ToppCell	(05)_Secretory-(2)_GFP_FOXI1\|(05)_Secretory / shred by cell type by condition	REST MTDH BRD4 KTN1	6.02e-06	199	27	4	d72d87e1e530ed894c0ad5e7b5b2b1d6b59fa098
ToppCell	(03)_KRT6B+-(2)_GFP_FOXI1\|(03)_KRT6B+ / shred by cell type by condition	REST BRD4 PCLO KTN1	6.02e-06	199	27	4	c425e7975f492ed5cfcca022248adb627e1d27d4
ToppCell	(01)_IL1RL1+-(2)_GFP_FOXI1\|(01)_IL1RL1+ / shred by cell type by condition	REST FKBP3 BRD4 KTN1	6.02e-06	199	27	4	a2f7d0cabf35b80fe239fae34a77bf9344d5d743
ToppCell	TCGA-Prostate-Primary_Tumor-Prostate_Adenocarcinoma-Acinar_Adenocarcinoma-7\|TCGA-Prostate / Sample_Type by Project: Shred V9	BCCIP FKBP3 MACO1	1.77e-04	182	27	3	af16334fec2c757b03c84cf252d00e92fa81e4cd
ToppCell	facs-Brain_Non-Myeloid-Cerebellum_-18m-Neuronal-interneuron\|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation	NRXN3 NRXN1 PCLO	1.92e-04	187	27	3	1b2fdbfb1ce3f19795dfc4b1da5a94f4b057ec41
ToppCell	wk_08-11-Hematologic-Meg-ery-Definitive_erythroblast\|wk_08-11 / Celltypes from embryonic and fetal-stage human lung	EP300 KIAA0232 MACO1	2.11e-04	193	27	3	be75abfdf5301cf33df8ee9ed92504d44fdf19a6
ToppCell	E16.5-Mesenchymal-Mesenchymal_structural-Fibroblastic-PMP-PMP_prolif\|E16.5 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif	MLLT3 CENPS PA2G4	2.14e-04	194	27	3	af4bbb2deb5a3913eb58990690fc3c62fbc3708c
ToppCell	Neuron-Postmitotic-Inhibitory_Neuron-MGE2\|World / Primary Cells by Cluster	NRXN3 NRXN1 PCLO	2.14e-04	194	27	3	b42fd64b0fb95434a9e4e6586f31d26114a4074b
ToppCell	Neuron-Postmitotic-Inhibitory_Neuron-MGE2-10\|World / Primary Cells by Cluster	NRXN3 NRXN1 PCLO	2.14e-04	194	27	3	81e7bc6516ab8d02ccd1c76a56a3533b788c27c8
ToppCell	Mid-temporal_gyrus_(MTG)-Neuronal\|Mid-temporal_gyrus_(MTG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types	NRXN3 NRXN1 PCLO	2.20e-04	196	27	3	676c56b44ac29f7baecb62f49bb8597cc74c0a88
ToppCell	Brain_organoid-organoid_Paulsen_bioRxiv-6_mon-Neuronal-PNs\|6_mon / Sample Type, Dataset, Time_group, and Cell type.	MLLT3 NRXN1 PCLO	2.24e-04	197	27	3	10e72b425a2bcba35e63a5b074d3dedcd49a762e
ToppCell	Brain_organoid-organoid_Kanton_Nature-Organoid-2M-Neuronal-ventral_progenitors_and_neurons_1\|Organoid-2M / Sample Type, Dataset, Time_group, and Cell type.	NRXN3 NRXN1 PCLO	2.24e-04	197	27	3	4961f66606f08e399508fd6cabca588e7ab406a8
ToppCell	primary_auditory_cortex_(A1C)-Neuronal\|primary_auditory_cortex_(A1C) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types	NRXN3 NRXN1 PCLO	2.27e-04	198	27	3	6d18b45eda4014759e6dd282d78ffd28df8a6044
ToppCell	Fetal_29-31_weeks-Epithelial-club_cell-D150\|Fetal_29-31_weeks / Lineage, Cell type, age group and donor	MLLT3 NRXN3 PCLO	2.27e-04	198	27	3	6ba5e5970109a04ed968bac7ff099ae250c579dc
ToppCell	Somatosensory_Cortex_(S1)-Neuronal\|Somatosensory_Cortex_(S1) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types	NRXN3 NRXN1 PCLO	2.27e-04	198	27	3	c01091ef18e096d792ea2a7a715764a5b215355f
ToppCell	Neuron-Postmitotic-Excitatory_Neuron_-Newborn-35\|World / Primary Cells by Cluster	MLLT3 NRXN3 NRXN1	2.27e-04	198	27	3	de5214a85fe017eb23d4aa8af624464f062ec57e
ToppCell	Primary_Motor_Cortex_(M1)-Neuronal\|Primary_Motor_Cortex_(M1) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types	NRXN3 NRXN1 PCLO	2.27e-04	198	27	3	4ca5ff320905ab4ff60ed90a5522227c782142a6
ToppCell	Neuron-Postmitotic\|World / Primary Cells by Cluster	MLLT3 NRXN1 PCLO	2.31e-04	199	27	3	1973527f8a7d4c6490d75c0d0ea153688166a08b
ToppCell	(02)_MMP9/10+-(2)_GFP_FOXI1\|(02)_MMP9/10+ / shred by cell type by condition	REST BRD4 KTN1	2.31e-04	199	27	3	18a7f9ced4364f45b184bd529f32ef02c27779d3
ToppCell	(10)_Ciliated-(2)_GFP_FOXI1\|(10)_Ciliated / shred by cell type by condition	REST BRD4 KTN1	2.31e-04	199	27	3	61b1ed2db71b96157b92b7535d1955a4033098da
ToppCell	(04)_Interm._basal>secr.-(2)_GFP_FOXI1\|(04)_Interm._basal>secr. / shred by cell type by condition	REST BRD4 KTN1	2.31e-04	199	27	3	53ca3861f9e00dab3f3fbefb0837857ee39ab084
ToppCell	(09)_Interm._secr.>cil.-(2)_GFP_FOXI1\|(09)_Interm._secr.>cil. / shred by cell type by condition	REST BRD4 KTN1	2.31e-04	199	27	3	fc680f85ebd3bab4c72876a19a461b0afb5f51ce
ToppCell	megakaryocytic-CD34+_Megakaryoblast\|megakaryocytic / Lineage and Cell class	PA2G4 MTDH KTN1	2.31e-04	199	27	3	99a65887d3c8a2cde26693dd74404b101bba9d58
ToppCell	Neuron\|World / Primary Cells by Cluster	MLLT3 NRXN1 PCLO	2.31e-04	199	27	3	1f8104fd92f04690b41d9d07ac08dc59d76bb97d
ToppCell	Brain_organoid-organoid_Kanton_Nature-Organoid-4M-Neuronal\|Organoid-4M / Sample Type, Dataset, Time_group, and Cell type.	NRXN1 MACO1 PCLO	2.31e-04	199	27	3	77b4aa00f14b86ef5db0490be98787e063979541
ToppCell	HSPCs\|World / Lineage and Cell class	PA2G4 FKBP3 HNRNPU	2.31e-04	199	27	3	df1ffc416c6946f1ba182f242a50ee41a571d565
ToppCell	(00)_Basal-(2)_GFP_FOXI1\|(00)_Basal / shred by cell type by condition	REST BRD4 KTN1	2.31e-04	199	27	3	19674e1eaeb51e4196d847cb62aa437c852951d3
ToppCell	Neuron-Postmitotic-Excitatory_Neuron_\|World / Primary Cells by Cluster	MLLT3 NRXN1 PCLO	2.31e-04	199	27	3	058373b4ac3cec2108cb24265628ff0a50646e33
ToppCell	Brain_organoid-organoid_Tanaka_cellReport-10w\|organoid_Tanaka_cellReport / Sample Type, Dataset, Time_group, and Cell type.	NRXN3 NRXN1 PCLO	2.34e-04	200	27	3	ac0e023dbb383bbc46c5cc525431778be8f7ef46
ToppCell	Fetal_brain-organoid_Tanaka_cellReport-GW16-Neuronal\|GW16 / Sample Type, Dataset, Time_group, and Cell type.	MLLT3 NRXN1 PCLO	2.34e-04	200	27	3	84e4565d28a02700bf7f6730d1b3a58744ca0aea
ToppCell	Neuron-Postmitotic-Excitatory_Neuron_-Upper_Layer\|World / Primary Cells by Cluster	ARHGAP20 NRXN1 PCLO	2.34e-04	200	27	3	db10f76938af553d1a2275bb02ef75dff3c3135b
ToppCell	Fetal_brain-fetalBrain_Zhong_nature-GW16-Neuronal\|GW16 / Sample Type, Dataset, Time_group, and Cell type.	MLLT3 NRXN1 PCLO	2.34e-04	200	27	3	1decf1d2cba5ebfd3e5cd4bcd637db8f193033ce
ToppCell	Fetal_brain-organoid_Tanaka_cellReport-GW16-Neuronal-Cortical_neuron\|GW16 / Sample Type, Dataset, Time_group, and Cell type.	MLLT3 NRXN1 PCLO	2.34e-04	200	27	3	19055194a5e0ea122f1b8fc62df44813f6843c95
ToppCell	Neuron-Postmitotic-Excitatory_Neuron_-Upper_Layer-21\|World / Primary Cells by Cluster	ARHGAP20 NRXN1 PCLO	2.34e-04	200	27	3	30a3e4aee12ec1b5acdce90f86c9733c27a7f6fc
ToppCell	Brain_organoid-organoid_Tanaka_cellReport-3m-Neuronal-Cortical_neuron\|3m / Sample Type, Dataset, Time_group, and Cell type.	MLLT3 NRXN1 PCLO	2.34e-04	200	27	3	c248233b004f8ef0bab3c65ecfe295887966f2ee
ToppCell	Brain_organoid-organoid_Tanaka_cellReport-3m-Neuronal\|3m / Sample Type, Dataset, Time_group, and Cell type.	MLLT3 NRXN1 PCLO	2.34e-04	200	27	3	af99d90070e2933fd2e9512590c6cf3bd6e15539
ToppCell	Brain_organoid-organoid_Tanaka_cellReport-10w-Neuronal-Interneuron\|10w / Sample Type, Dataset, Time_group, and Cell type.	NRXN3 NRXN1 PCLO	2.34e-04	200	27	3	f5c63ef52bd7a898cf009b8bf9b2f7f4890d1c9b
Drug	Fluocinonide [356-12-7]; Down 200; 8uM; PC3; HT_HG-U133A	CYLC1 MLLT3 NRXN3 MACO1 HNRNPU	3.27e-06	198	27	5	3757_DN
Drug	6-chloro-2,3,4,9-tetrahydro-1H-carbazole-1-carboxamide	REST EP300 BRD4	3.16e-05	52	27	3	ctd:C550547
Drug	Kawain [500-64-1]; Down 200; 17.4uM; MCF7; HT_HG-U133A	MBTD1 ZNF609 REST HNRNPU	7.10e-05	190	27	4	2299_DN
Drug	Apomorphine hydrochloride hemihydrate [41372-20-7]; Down 200; 6.4uM; MCF7; HT_HG-U133A	MBTD1 ZNF609 BRD4 HNRNPU	7.85e-05	195	27	4	1505_DN
Drug	Hesperetin [520-33-2]; Down 200; 13.2uM; MCF7; HT_HG-U133A	CYLC1 MBTD1 ZNF609 BRD4	8.00e-05	196	27	4	1531_DN
Drug	Dobutamine hydrochloride [49745-95-1]; Down 200; 11.8uM; MCF7; HT_HG-U133A	CYLC1 MBTD1 ZNF609 HNRNPU	8.00e-05	196	27	4	5386_DN
Drug	Isoniazid [54-85-3]; Up 200; 29.2uM; HL60; HG-U133A	ZNF609 FEZ2 EP300 KTN1	8.00e-05	196	27	4	1399_UP
Drug	Mecamylamine hydrochloride [826-39-1]; Up 200; 19.6uM; PC3; HT_HG-U133A	CYLC1 MBTD1 NRXN3 BRD4	8.00e-05	196	27	4	7263_UP
Drug	Metrizamide [31112-62-6]; Down 200; 5uM; MCF7; HT_HG-U133A	CYLC1 MBTD1 ZNF609 REST	8.00e-05	196	27	4	3255_DN
Drug	Thioproperazine dimesylate [2347-80-0]; Up 200; 6.2uM; PC3; HT_HG-U133A	CYLC1 MBTD1 ZNF609 BRD4	8.00e-05	196	27	4	2073_UP
Drug	Midecamycin [35457-80-8]; Down 200; 5uM; MCF7; HT_HG-U133A	MBTD1 ZNF609 BRD4 HNRNPU	8.16e-05	197	27	4	1526_DN
Drug	Mianserine hydrochloride [21535-47-7]; Up 200; 13.2uM; HL60; HG-U133A	MBTD1 ZNF609 FEZ2 MACO1	8.16e-05	197	27	4	1385_UP
Drug	Pentolinium bitartrate [52-62-0]; Down 200; 7.4uM; MCF7; HT_HG-U133A	CYLC1 ZNF609 REST MACO1	8.16e-05	197	27	4	4699_DN
Drug	Sulfacetamide sodic hydrate [6209-17-2]; Up 200; 15.8uM; HL60; HT_HG-U133A	MLLT3 ZNF609 REST FEZ2	8.32e-05	198	27	4	1859_UP
Drug	Risperidone [106266-06-2]; Up 200; 9.8uM; HL60; HT_HG-U133A	MLLT3 ZNF609 BRD4 HNRNPU	8.32e-05	198	27	4	2947_UP
Drug	Dihydroergocristine mesylate [24730-10-7]; Up 200; 5.6uM; PC3; HT_HG-U133A	CYLC1 MBTD1 ZNF609 NRXN3	8.49e-05	199	27	4	7275_UP
Drug	Clonidine hydrochloride [4205-91-8]; Down 200; 15uM; MCF7; HT_HG-U133A	MLLT3 ZNF609 REST HNRNPU	8.49e-05	199	27	4	6814_DN
Drug	AC1NB8R3	NRXN3 REST NRXN1 HNRNPU	1.10e-04	213	27	4	CID004489307
Disease	Schizoaffective disorder-bipolar type	NRXN3 PCLO	9.60e-05	16	27	2	EFO_0009965
Disease	platelet measurement	PWWP2A RALB REST KIAA0232	1.84e-04	315	27	4	EFO_0005036
Disease	caudate volume change measurement, age at assessment	NRXN3 NRXN1	2.79e-04	27	27	2	EFO_0008007, EFO_0021491
Disease	mean reticulocyte volume	MLLT3 REST KIN MACO1 BRD4	7.07e-04	799	27	5	EFO_0010701
Disease	pain	C1D REST NRXN1	7.51e-04	196	27	3	EFO_0003843
Disease	intraocular pressure measurement	RALB ARHGAP20 FEZ2 PCLO	1.12e-03	509	27	4	EFO_0004695
Disease	obsolete_red blood cell distribution width	BCCIP REST MTDH EP300 KIAA0232 BRD4	1.16e-03	1347	27	6	EFO_0005192
Disease	word reading	MLLT3 NRXN3	1.62e-03	65	27	2	EFO_0005300
Disease	Alcoholic Intoxication, Chronic	C1D NRXN3 EP300	1.84e-03	268	27	3	C0001973
Disease	Autism Spectrum Disorders	NRXN3 NRXN1	2.75e-03	85	27	2	C1510586
Disease	migraine disorder, Headache	C1D REST	2.81e-03	86	27	2	HP_0002315, MONDO_0005277
Disease	coronary artery disease	C1D MBTD1 REST ARHGAP20 NRXN1	4.13e-03	1194	27	5	EFO_0001645
Disease	platelet component distribution width	PWWP2A RALB MLLT3 KIAA0232	4.67e-03	755	27	4	EFO_0007984
Disease	risk-taking behaviour	NRXN3 REST NRXN1 EP300	4.87e-03	764	27	4	EFO_0008579
Disease	alcohol consumption measurement	NRXN3 REST NRXN1 EP300 PCLO	4.88e-03	1242	27	5	EFO_0007878
Disease	irritable bowel syndrome	EP300 PCLO	6.38e-03	131	27	2	EFO_0000555

Protein segments in the cluster

Peptide	Gene	Start	Entry
TKGDSKNAKKKNNKK	EP300	1541	Q09472
KAQKKKKSEDGSKNS	CENPS	111	Q8N2Z9
KKTKKNNSSNSNVSK	BRD4	571	O60885
NKSSKESSKKPKENK	MLLT3	226	P42568
DKNGKKSSKNKKSFK	RALB	186	P11234
QSSTQSKEKKKKKSA	KIN	246	O60870
TQKKKKKKASKTAEN	PA2G4	366	Q9UQ80
TKKKKKVESKSKNNS	REST	541	Q13127
AKSSNKNKKNKDKEY	NRXN1	456	P58400
ASSKQKKKAKSQQYK	MBTD1	571	Q05BQ5
KNNSKKKPSNKKKAA	BCCIP	231	Q9P287
KSKNASKVANKGKSK	C1D	126	Q13901
SSSKNEKKQKCTSKS	MACO1	346	Q8N5G2
EQQQRKSSSKKSKKD	PCLO	1796	Q9Y6V0
KTQSKSKNEKENKFS	KIAA0232	246	Q92628
VSKNCSQKDKKDSKN	CYLC1	191	P35663
SQKDKKDSKNSKKTN	CYLC1	196	P35663
KKDSKTDNKKSVKND	CYLC1	426	P35663
KKQNTGSKKSNKNKS	HNRNPU	681	Q00839
KEKQQSSKSGHKKQK	NRXN3	1621	Q9Y4C0
SQKKSSQKKSSKKNH	ISG20L2	136	Q9H9L3
SGKKKASSKKQKTEN	KTN1	206	Q86UP2
AKSSNKNKKNKDKEY	NRXN1	1461	Q9ULB1
DTNIQTSAKKKKNAK	FKBP3	146	Q00688
KKKSKSDAKAVQNSS	MTDH	166	Q86UE4
TAKKKKKLKNGSSQN	FEZ2	276	Q9UHY8
DVSKKNATTQNTKKK	ARHGAP20	766	Q9P2F6
KEKAQKKQNETSTSK	PWWP2A	436	Q96N64
KEKKSKSDDKNENKN	CNGA1	106	P29973
SKKEKENSSSKSKKE	ZNF609	156	O15014